Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010;Radiothérapie des cancers métastatiques ou oligométastatiques en dehors des irradiations à visée antalgique. État des lieux en 2010 avec focus sur l'asco 2010

Bulletin du Cancer

Volumn 97, Issue 12, 2010, Pages 1467-1476

  Thariat, J ^a   Marcy, P Y ^b   Lagrange, J L ^c  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Chemotherapy; Curative; Metastasis; Oligometastatic; Palliative; Primary cancer; Radiotherapy; Stereotactic; Targeted therapy

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; HUMAN; LIVER DISEASE; METASTASIS; OLIGOMETASTATIC DISEASE; PRIMARY TUMOR; RADIATION INJURY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; BONE TUMOR; BRAIN TUMOR; BREAST TUMOR; FEMALE; LIVER TUMOR; LUNG TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; SPINAL CORD COMPRESSION;

ANGIOGENESIS INHIBITOR; PROTEIN KINASE INHIBITOR;

ANGIOGENESIS INHIBITORS; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; PROTEIN KINASE INHIBITORS; SPINAL CORD COMPRESSION;

EID: 79251524586     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1230     Document Type: Review

References (38)

1. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5: e9584.
2. Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol 2010;33:157-63.
3. Gerard JP, Thariat J, Giraud P, Cosset JM. Past, present and near future of techniques in radiation oncology. Bull Cancer 2010;97:743-51.
4. Noel G, Boisserie G, Feuvret L, Mazeron JJ. Radiosurgery of brain metastasis: reflexions, controversies and unanswered questions in 2004. Bull Cancer 2004;91:81-93.
5. ® robotic stereotactic radiotherapy: technical aspects and recent developments. Bull Cancer 2010;97:807-18.
6. Kirova Y, Chargari C, Mazeron J. Métastases céré brales multiples d'un cancer du sein et leur prise en charge en radiothérapie: quelle est l'attitude thérapeutique la mieux adaptée? Bull Cancer 2010 (in press).
7. Giraud P, Garcia R. Respiratory gating for radiotherapy: main technical aspects and clinical benefits. Bull Cancer 2010 Jul; 97 (7):847-56.
8. Macdermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 2008;98:202-6.
9. ® radiotherapy for lung cancer: early results. Cancer Radiother 2008;12:793-9.
10. Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006;45:808-17.
11. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-84.
12. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006;16:77-84.
13. ®. Cancer Radiother 2010;14:438-41.
14. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1.001 consecutive cases. Ann Surg 1999;230:309-18 (discussion 18-21).
15. De Bari B, Pointreau Y, Rio E, Mirabel X, Mornex F. Normal tissue tolerance to external beam radiation therapy: liver. Cancer Radiother 2010;14:344-9.
16. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8.
17. Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neuro-Oncol 2010;96:85-96.
18. Graham PH, Bucci J, Browne L. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. Int J Radiat Oncol Biol Phys 2010;77:648-54.
19. Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study. J Clin Oncol 2010 [Epub ahead of print].
20. Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008;70:187-93.
21. ®. Cancer Radiother 2010;14:438-41.
22. Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, et al. Radiotherapy for Patients with metastases to the spinal column: a review of 603 patients at shizuoka cancer center hospital. Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print].
23. Choi CY, Adler JR, Gibbs IC, Chang SD, Jackson PS, Minn AY, et al. Stereotactic Radiosurgery for Treatment of Spinal Metastases Recurring in Close Proximity to Previously Irradiated Spinal Cord. Int J Radiat Oncol Biol Phys 2010;78:499-506.
24. Rades D, Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, et al. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print].
25. Konski A, James J, Hartsell W, Leibenhaut MH, Janjan N, Curran W, et al. Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol 2009;32:423-8.
26. Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol 2009;27:1375-81.
27. Bourgier C, Khodari W, Vataire AL, Pessoa EL, Dunant A, Delaloge S, et al. Breast radiotherapy as part of locoregional treatments in stage IV breast cancer patients with oligometastatic disease. Radiother Oncol 2010;96:199-203.
28. Ali D, Le Scodan R. Treatment of the primary tumor in breast cancer patients with synchronous metastases. Ann Oncol 2010 [Epub ahead of print].
29. Cassier PA, Ray-Coquard I, Sunyach MP, Lancry L, Guastalla JP, Ferlay C, et al. A phase II trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer. Cancer 2008;113:2532-8.
30. Diaz O, Mazeron R, Martin E, Carrie C. Toxicity of radiation therapy and antiangiogenics combination: a case report. Cancer Radiother 2009;13:205-8.
31. Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, et al. Phase I study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer 2009;115:3571-80.
32. Olmez I, Donahue BR, Butler JS, Huang Y, Rubin P, Xu Y. Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis. Lung Cancer 2010;70:174-9.
33. Platini C. Trastuzumab and blood-brain barrier. Bull Cancer 2007;94:857-9.
34. Chargari C, Idrissi HR, Pierga JY, Bollet MA, Dieras V, Campana F, et al. Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients. Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print].
35. Niwinska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol 2010;21:942-8.
36. Gripp S, Mjartan S, Boelke E, Willers R. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer 2010;116:3251-6.
37. Grabarz D, Panzarella T, Bezjak A, McLean M, Elder C, Wong RK. Quantifying interobserver variation in target definition in palliative radiotherapy. Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print].
38. Ruhl R, Ludemann L, Czarnecka A, Streitparth F, Seidensticker M, Mohnike K, et al. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiat Oncol 2010;5:44.